Cardax, Inc. CDXI OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score

27/100

0/4 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Cardax, Inc. (CDXI) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 25/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

27/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✗

HEALTH

0/100

Debt-to-Equity & liquidity

→ Health

MOAT

50/100

→ Income

GROWTH

58/100

→ Income

—

INCOME

N/A

No coverage

Valuation Snapshot — CDXI

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio0.00

EV/EBITDA0.0

Per Share Data

EPS (TTM)$0.00

Book Value / Share$0.00

Revenue / Share$0.00

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2013	$-0.28	$75.35K	$-65.16K	-86.5%
2014	$-56.44	$0.00	$-16.99M	-
2015	$-12.73	$0.00	$-4.26M	-
2016	$-4.68	$35.26K	$-1.78M	-5059%
2017	$-3.97	$610.32K	$-1.99M	-325.3%
2018	$-6.32	$1.51M	$-4.02M	-266.4%
2019	$-8.40	$710.95K	$-5.72M	-804.1%
2020	$-9.82	$538.95K	$-7.31M	-1356.8%
2021	$0.00	$0.00	$0.00	-
2022	$0.00	$0.00	$0.00	-